EUVIMEDEUVIMED entdecken
Crossref

Rational Design of Dual-Functionalized Gd@C 82 Nanoparticles to Relieve Neuronal Cytotoxicity in Alzheimer’s Disease via Inhibition of Aβ Aggregation

Xiuhua Yin, Hong Zhou, Tiantian Cao, Xiner Yang, Fei Meng, Xing Dai iD, Yifan Wang, Sijie Li, Wangsong Zhai, Zaixing Yang iD, Ning Chen iD, Ruhong Zhou iD

ACS Nano · 18.06.2024 · 18 (24) · 15416-15431

DOI: 10.1021/acsnano.3c08823 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Nano, online erschienen am 05.06.2024. Verfasst von Xiuhua Yin und 11 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Quantitative Biology, Shanghai Institute for Advanced Study, College of Life Sciences, Zhejiang University, Hangzhou 310027, China. Hauptthemen laut MEDLINE: Alzheimer Disease, Amyloid beta-Peptides, Nanoparticles, Neurons. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 127 Literaturangaben. Gefördert von: Zhejiang University, Natural Science Research of Jiangsu Higher Education Institutions of China, National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The accumulation of amyloid-β (Aβ) peptides is a major hallmark of Alzheimer's disease (AD) and plays a crucial role in its pathogenesis. Particularly, the structured oligomeric species rich in β-sheet formations were implicated in neuronal organelle damage. Addressing this formidable challenge requires identifying candidates capable of inhibiting peptide aggregation or disaggregating preformed oligomers for effective antiaggregation-based AD therapy. Here, we present a dual-functional nanoinhibitor meticulously designed to target the aggregation driving force and amyloid fibril spatial structure. Leveraging the exceptional structural stability and facile tailoring capability of endohedral metallofullerene Gd@C82, we introduce desired hydrogen-binding sites and charged groups, which are abundant on its surface for specific designs. Impressively, these designs endow the resultant functionalized-Gd@C82 nanoparticles (f-Gd@C82 NPs) with high capability of redirecting peptide self-assembly toward disordered, off-pathway species, obstructing the early growth of protofibrils, and disaggregating the preformed well-ordered protofibrils or even mature Aβ fibrils. This results in considerable alleviation of Aβ peptide-induced neuronal cytotoxicity, rescuing neuronal death and synaptic loss in primary neuron models. Notably, these modifications significantly improved the dispersibility of f-Gd@C82 NPs, thus substantially enhancing its bioavailability. Moreover, f-Gd@C82 NPs demonstrate excellent cytocompatibility with various cell lines and possess the ability to penetrate the blood-brain barrier in mice. Large-scale molecular dynamics simulations illuminate the inhibition and disaggregation mechanisms. Our design successfully overcomes the limitations of other nanocandidates, which often overly rely on hydrophobic interactions or photothermal conversion properties, and offers a viable direction for developing anti-AD agents through the inhibition and even reversal of Aβ aggregation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseAmyloid beta-PeptidesNanoparticlesNeuronsAnimalsHumansMiceRatsCell SurvivalDrug DesignFullerenesGadoliniumProtein Aggregates

Stichwörter der Autor:innen

Alzheimer’s diseaseaggregation inhibitorfunctionalized Gd@C82 nanoparticlerational designrestore synaptic loss

Substanzen

Amyloid beta-PeptidesFullerenesGadoliniumProtein Aggregates

Autor:innen und Institutionen

  • Institute of Quantitative Biology, Shanghai Institute for Advanced Study, College of Life Sciences, Zhejiang University, Hangzhou 310027, China.
  • State Key Laboratory of Radiation Medicine and Protection, School for Radiological and Interdisciplinary Sciences (RAD-X), Soochow University, Suzhou 215123, China.
  • College of Chemistry, Chemical Engineering and Materials Science, Soochow University, Suzhou 215123, China.
  • Suzhou Institute of Trade and Commerce, Suzhou 215009, China.
  • Department of Chemistry, Columbia University, New York, New York 10027, United States.

ORCID-Profile: Xing Dai, Zaixing Yang, Ning Chen, Ruhong Zhou

Förderung

  • Zhejiang University
  • Natural Science Research of Jiangsu Higher Education Institutions of China
  • National Key Research and Development Program of China
  • National Natural Science Foundation of China
  • Shanghai Artificial Intelligence Lab
  • National Center of Technology Innovation for Biopharmaceuticals
  • Shanghai Zhangjiang Independent Innovation Demonstration Zone

Zitieren

APA

Yin, X., Zhou, H., Cao, T., Yang, X., Meng, F., Dai, X., Wang, Y., Li, S., Zhai, W., Yang, Z., Chen, N., & Zhou, R. (2024). Rational Design of Dual-Functionalized Gd@C 82 Nanoparticles to Relieve Neuronal Cytotoxicity in Alzheimer’s Disease via Inhibition of Aβ Aggregation. ACS Nano, 18(24), 15416-15431. https://doi.org/10.1021/acsnano.3c08823

Vancouver

Yin X, Zhou H, Cao T, Yang X, Meng F, Dai X, et al. Rational Design of Dual-Functionalized Gd@C 82 Nanoparticles to Relieve Neuronal Cytotoxicity in Alzheimer’s Disease via Inhibition of Aβ Aggregation. ACS Nano. 2024;18(24):15416-15431. doi:10.1021/acsnano.3c08823

BibTeX
@article{Yin2024,
  author = {Yin, Xiuhua and Zhou, Hong and Cao, Tiantian and Yang, Xiner and Meng, Fei and Dai, Xing and Wang, Yifan and Li, Sijie and Zhai, Wangsong and Yang, Zaixing and Chen, Ning and Zhou, Ruhong},
  title = {Rational Design of Dual-Functionalized Gd@C 82 Nanoparticles to Relieve Neuronal Cytotoxicity in Alzheimer’s Disease via Inhibition of Aβ Aggregation},
  journal = {ACS Nano},
  year = {2024},
  volume = {18},
  number = {24},
  pages = {15416--15431},
  doi = {10.1021/acsnano.3c08823}
}
Kostenlos starten →